Estradiol - MIGENIX
Alternative Names: CardioStat; MITO-0139; NeuroStatLatest Information Update: 19 Dec 2021
At a glance
- Originator MIGENIX
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 15 Jun 2007 Discontinued - Preclinical for Stroke in USA (SC)
- 21 Sep 2004 Micrologix Biotech is now called MIGENIX
- 15 Oct 2002 This agent is still in active development